Skip to main content

Table 1 Correlation between circ0120816 expression and clinical features of ESCC patients

From: Circ0120816 acts as an oncogene of esophageal squamous cell carcinoma by inhibiting miR-1305 and releasing TXNRD1

Characteristics Total = 36 Expression of circ0120816 P valuea
High (n = 20) Low (n = 16)
Age(years)   0.765
  ≤ 60 17 (47.2%) 9 (45.0%) 8 (50.0%)  
  > 60 19 (52.8%) 11 (55.0%) 8 (50.0%)  
Gender   0.940
 Female 16 (44.4%) 9 (45.0%) 7 (43.8%)  
 Male 20 (55.6%) 11 (55.0%) 9 (56.2%)  
Tumor location in esophagus   0.491
 Upper 8 (22.2%) 3 (15.0%) 5 (31.3%)  
 Middle 17 (47.2%) 10 (50.0%) 7 (43.7%)  
 Lower 11 (30.6%) 7 (35.0%) 4 (25.0%)  
Pathological T stage   0.020b
 T1 10 (27.8%) 2 (15.0%) 8 (43.8%)  
 T2 16 (44.4%) 10 (45.0%) 6 (43.8%)  
 T3 10 (27.8%) 8 (40.0%) 2 (12.5%)  
Lymph node metastasis   
 No 21 (58.3%) 7 (35.0%) 14 (87.5%) 0.001b
 Yes 15 (41.7%) 13 (65.0%) 2 (12.5%)  
Differentiation   0.285
 Well 7 (19.4%) 3 (25%) 4 (7.4%)  
 Moderately 20 (55.6%) 10 (55%) 10 (51.9%)  
 Poorly 9 (25.0%) 7 (20%) 2 (40.7%)  
  1. aP value comparison between higher and lower circ0120816 expression (cut by the mean level) in ESCC tumor tissues; bP < 0.05